Reyon Pharmaceutical Co Ltd banner
R

Reyon Pharmaceutical Co Ltd
KRX:102460

Watchlist Manager
Reyon Pharmaceutical Co Ltd
KRX:102460
Watchlist
Price: 10 000 KRW -1.38% Market Closed
Market Cap: ₩185.9B

Bankruptcy Probability

Reyon Pharmaceutical Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .

We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.

Probability of Bankruptcy
LOCKED
Unlock

Financial Position

Cash & Short-Term Investments
+
3Y
-85%
5Y
-90%
10Y
+533%
Long-Term Investments
+
3Y
-32%
5Y
-17%
10Y
-79%
Debt
+
3Y
-35%
5Y
+65%
10Y
+6 714%

Solvency Ratios

Solvency Ratios Comparison
Reyon Pharmaceutical Co Ltd Competitors

Country Company Market Cap D/E D/A Interest
Coverage
Altman
Z-Score
Quick
Ratio
Current
Ratio
Cash
Ratio
KR
Reyon Pharmaceutical Co Ltd
KRX:102460
183.4B KRW
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1.2T USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
643.9B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
JP
Hisamitsu Pharmaceutical Co Inc
TSE:4530
70.4T JPY
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
368B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
240.1B CHF
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
189.8B GBP
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
243.1B USD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
CA
Nuvo Pharmaceuticals Inc
TSX:MRV
297.3B CAD
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
No Stocks Found
Is Reyon Pharmaceutical Co Ltd at risk of bankruptcy?

Reyon Pharmaceutical Co Ltd's probability of bankruptcy is Hidden .

The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.

How much debt does Reyon Pharmaceutical Co Ltd have?

As of the latest report, Reyon Pharmaceutical Co Ltd has total debt of 136.3B KRW. This includes both short-term (40.7B KRW) and long-term (95.6B KRW) debt.

You can find a full breakdown on its Balance Sheet.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett